Epilepsia Refratária e Lamotrigina: Monitorização terapêutica e resposta clínica em pacientes ambulatoriais

Baldoni, André de Oliveira

doi:10.11606/t.60.2013.tde-27092013-141728

Cited by 1 publication

(1 citation statement)

References 35 publications

(41 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of patients in combination therapy found in this study is in agreement with other studies conducted with patients with drug‐resistant epilepsy, since one of the main strategies for the control of seizures in drug‐resistant epilepsy is the association of AEDs.…”

Section: Discussionsupporting

confidence: 91%

Drug‐resistant epilepsy and topiramate: Plasma concentration and frequency of epileptic seizures

Marques

Albuquerque

Campos

et al. 2018

Clin Exp Pharma Physio

View full text Add to dashboard Cite

Topiramate (TPM) is a second-generation antiepileptic drug (AED), acting on drug-resistant epilepsy. The aim of the study was to evaluate the influence of the dose, use of other AEDs on TPM plasma concentration (C ), and frequency of epileptic seizures. A cross-sectional analytical study was developed with patients aged 18-60 years, for diagnosis of drug-resistant epilepsy, using TPM in monotherapy or associated with other AEDs. The following variables were analyzed: age, frequency of epileptic seizures, pharmacotherapeutic regimen with its respective doses, adherence to medication treatment, and adverse events score. Thirty-seven patients were included, 83.8% of the patients presented C below the therapeutic range. Multiple linear regression estimated that the increase of 1.0 mg/kg/d promoted an increase of 0.68 μg/mL in TPMC , while the use of inducers predicted a reduction of 2.97 μg/mL (P < .001). Multiple Poisson regression predicts that an increase of 1.0 μg/mL in TPMC decreased the patient's chance of presenting seizures, and patients using AED inducers were about ten times more likely to present seizures than those who do not use (P < .001). In addition, for patients using AED inducers with C below the therapeutic range, the mean number of seizures per month was greater than those with C within the therapeutic range. The prescribed dose and the use of AED inducers influence C of TPM, likewise the low C of first-line AEDs and of the adjuvant in the treatment, TPM, as well as low TPM dose seem to affect the control of epileptic seizures.

show abstract

Section: Discussionsupporting

confidence: 91%